Search
for
Sort by
Research 391–420 of 1000+
- 646 SOX4 is essential for melanoma tumorigenesis
- Molecular mapping of lymph node metastases by real-time reverse transcription polymerase chain reaction in two melanoma patients
- Anti-invasive effects of minoxidil on human breast cancer cells: combination with ranolazine
- Trichomegaly of the eyelashes following treatment with cetuximab
- Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Gene profile analysis of colorectal cancer cell lines by cDNA macroarray
- Cutaneous Crohn's disease treated with infliximab and 4 years of follow up
- Alopecia Areata Associated with Thymoma Presenting as a Diffuse Pleural Dissemination Mimicking Mesothelioma: Rare Concomitant Presentation
- Erlotinib-related Severe Hair Loss with Severe Exanthematous Drug Eruption: A Case Report
- Functional analysis of thymosin beta-4 using over-expressing transgenic mice
- Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
- Incidence and management of cutaneous toxicities associated with cetuximab
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Clinical Case Notes. Tamoxifen optic neuropathy
- TRAPPED IN THE HYPOGLYCEMIA LOOP
- IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY
- Skin Toxicity in Palliative Radiation Therapy
- miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Rapid hair depigmentation in patient treated with pazopanib
- In-Vitro Anticancer Activity of Chemical Constituents from Etlingera alba Poulsen against Triple Negative Breast Cancer and in silico Approaches towards Matrix metalloproteinase-1 Inhibition
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Sacituzumab Govitecan-Hziy (Trodelvy™)
- A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative)
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Protein Kinase C Epsilon Signals Ultraviolet Light-induced Cutaneous Damage and Development of Squamous Cell Carcinoma Possibly Through Induction of Specific Cytokines in a Paracrine Mechanism¶